Skip to main content
Caplight Logo









Nimble Science

Nimble Science

Private
CalgaryHealthcare & Life Scienceshttps://www.nimblesci.com/

Last Round

VC Round

Oct 1, 2025

Total Funding Raised

$2.5M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Nimble Science is a health technology company that provides a multi-omic data platform and an ingestible device, the SIMBA™ Capsule, for sampling the microenvironment of the small intestine.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Non-AI

Keywords

microbiome researchingestible capsulesmart pillgastrointestinal diagnosticsprecision medicinemulti-omicsclinical trial toolscontract research organizationCROnon-invasive samplinggut health datadata as a serviceDaaSmetagenomicsmedical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nimble Science Comparables

Compare Nimble Science with similar companies based on industry and business-model similarity.

Nimble Science comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Envivo Bio
91%
Microvitality
88%
Pelican Health
85%

Nimble Science Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundOct 1, 2025
SeedApr 18, 2024
AcceleratorMar 7, 2024
SeedJan 24, 2024
SeedApr 4, 2023

Key People

Founding team and executive leadership

Sabina Bruehlmann

Chief Executive Officer

Executive Team

Joseph Wang

Chief Technology Officer

Executive Team

Nimble Science Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 1, 2025

    Corundum Systems Biology participated in the VC Round.

  • Sep 3, 2025

    SIMBA(TM) Capsule receives approval from Health Canada.

Nimble Science Filings

Explore SEC and related filing metadata, where available.

Nimble Science filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Nimble Science's valuation, stock price, and market status.

Is Nimble Science a public or private company?

Nimble Science is a private company.

What is the current stock price of Nimble Science?

Nimble Science is a private company with no public stock price. No recent secondary market data is available.

How much is Nimble Science worth (valuation)?

Valuation information for Nimble Science is not publicly available.

Can I buy Nimble Science stock?

Nimble Science shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Nimble Science's last funding round?

Nimble Science's most recent funding round was Seed on April 18, 2024.

Who are the main investors in Nimble Science?

Key investors in Nimble Science include Fusion Fund, Seventure Partners.

Will Nimble Science IPO soon?

No public IPO plans have been announced for Nimble Science.

How can I track Nimble Science secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nimble Science's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCalgary
Employee Range29
Year Founded2018
Last FundingOct 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?